What Does AOD9604 Do in Research
There is no official link established between semaglutide and direct follicular toxicity, and hair loss is not listed as a recognised adverse drug reaction in regulatory documentation from the MHRA or EMA
The same principle applies when using a smaller vial
This can result from chronic inflammation, poor diet, lack of sleep, overtraining, illness, or environmental toxin exposure
This study population was divided into two cohorts: (1) Semaglutide cohort 25,843 patients prescribed semaglutide, and (2) Non-GLP-1RA anti-diabetes medication cohort 562,006 patients prescribed non-GLP-1RA anti-diabetes medications but not semaglutide
This latest research suggests it can also be a valuable preventative treatment for people at high risk of heart conditions.